Verge Genomics
We use human data and AI to develop better drugs faster.
Y CombinatorSummer 2015ActiveHealthcareDrug Discovery and Delivery
What they do
Problem
Traditional drug discovery is slow, expensive, and often fails because targets and therapies are not well validated in humans.
Solution
Verge Genomics uses AI and proprietary human patient genomics data to identify and validate drug targets and develop new therapies end-to-end.
Who it's for
Biopharma companies and internal R&D teams developing new drugs.
Founders
Alice Zhang
Founder/CEO
Company timeline
- Founded2015
- YC batchSummer 2015
- StatusActive
- Team size50 people
- LocationSan Francisco, CA, USA
Similar startups
Octant Bio
The octant was the dominant tool for maritime navigation in the 18th…
Anthrogen
We're training the next generation of protein foundation models.
Insitro
Drug design is fundamentally a data science problem. Naturally, data…
Inceptive
Foundation models for molecule design, customized for partners to ena…
Ångström AI
Gen AI molecular simulations that reproduce wetlab results
Deepcell
Integrated platform for imaging, AI-powered analysis and enrichment o…